Lycia Therapeutics is a biotechnology company headquartered in South San Francisco, California, focused on discovering and developing novel targeted therapeutics using its proprietary protein degradation technology.
Subscribe to see Lycia Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lycia Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $277M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round raised $75M in June 2026. Xcout tracks 11 named people at Lycia Therapeutics, Inc., including Aetna Wun Trombley (President and Chief Executive Officer). Xcout recorded 1 job posting from Lycia Therapeutics, Inc. in the last 90 days.
5 more named people on record for Lycia Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $277M raised across the 5 rounds on record (4 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $75M | — | |
| Series D | $106.6M | 10 named | |
| — | $70.1M | 11 named | |
| — | Undisclosed | 10 named | |
| SEC Form D filing | $25.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 1 job posting from Lycia Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Lycia Therapeutics, Inc.'s hiring signals →
A few of Lycia Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Rezo Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, that integrates proteomics, genetics, and structural biology for drug discovery and development.
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
Link Cell Therapies Inc. is a platform biotechnology company maintaining its headquarters in South San Francisco, California. The company develops novel agents targeting hematologic and related diseases.
Gordian Biotechnology is a biotechnology research company headquartered in South San Francisco, California. The company focuses on curing age-related diseases through in vivo target discovery and functional genomics platforms.
Laigo Bio is a biotechnology company that develops targeted protein degradation therapeutics using its proprietary SureTAC platform. The company utilizes bispecific antibodies to direct cell surface targets toward lysosomal degradation, primarily serving the oncology and immunology sectors.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Lycia Therapeutics, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.